Scientists test triple punch to reboot immune system against stubborn cancers
NCT ID NCT03474497
Summary
This study is testing a new combination treatment for people with advanced lung cancer, melanoma, kidney cancer, or head and neck cancer that has stopped responding to standard immunotherapy. The treatment involves three parts: a targeted radiation dose to one tumor, injections of an immune-stimulating drug into that same tumor, and continued standard immunotherapy. The main goal is to see if this approach can restart the body's immune system to attack cancer elsewhere in the body and is safe for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UC Davis Medical Center
Sacramento, California, 95817, United States
-
University of California Davis Medical Center
Sacramento, California, 97817, United States
Conditions
Explore the condition pages connected to this study.